Health technology assessment in Brazil - an international perspective

被引:17
|
作者
Gomes Lima, Sandra Goncalves [1 ]
de Brito, Claudia [2 ]
Coelho de Andrade, Carlos Jose [1 ]
机构
[1] Inst Nacl Canc Jose Alencar Gomes da Silva, R Equador 831, BR-20220410 Rio De Janeiro, RJ, Brazil
[2] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil
来源
CIENCIA & SAUDE COLETIVA | 2019年 / 24卷 / 05期
关键词
Health investment; Technological development; Health technology assessment; Unified Health System;
D O I
10.1590/1413-81232018245.17582017
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Given the financial impact of the adoption of new health technologies in health systems, choosing what technology should be introduced and when poses a major challenge for health managers. The health technology assessment (HTA) process should therefore be underpinned by transparent and objective criteria. The objective of this study was to analyze HTA processes in Brazil, overseen by the National Commission for the Incorporation of Health Technology (CONITEC), and to compare these processes with those in countries considered to be at the forefront of this field: Australia, Canada, and the United Kingdom. The following categories were used for the comparative analysis: program structure, definition and selection of topics, evidence review, use of HTA in decision making, program products and dissemination, and transparency. The findings show that there are more similarities than differences between these countries' processes and the CONITEC processes. The main differences identified were: composition of committees, entitlement to appeal, program evaluation, and timeframes for the implementation of recommendations/decisions. Despite making major strides in recent years, Brazil should continue to promote continuous improvement of its HTA process.
引用
收藏
页码:1708 / 1721
页数:14
相关论文
共 50 条